Di Maira Giovanni, Brustolon Francesca, Pinna Lorenzo A, Ruzzene Maria
Department of Biological Chemistry and CNR Neuroscience Institute, University of Padova, Padova, Italy.
Cell Mol Life Sci. 2009 Oct;66(20):3363-73. doi: 10.1007/s00018-009-0108-1. Epub 2009 Aug 8.
Akt (PKB) is a critical kinase in cell-survival pathways. Its activity depends on the phosphorylation of Thr308 and Ser473, by PDK1 and mTORC2, respectively. We found that Akt can be further stimulated through phosphorylation of Ser129 by another kinase, CK2. Here we show that phosphorylation of Akt at Ser129 also facilitates its association with Hsp90 chaperone, thus preventing Thr308 dephosphorylation. This is supported by the following observations: (1) phospho-Thr308 decreases when Ser129 is mutated to alanine, (2) this decrease is abolished by cell treatment with okadaic acid (to inactivate PP2A) or geldanamycin (to inactivate Hsp90), (3) phosphorylation of Ser129 neither enhances the activity of PDK1 nor hampers the in vitro activity of PP2A on Thr308, but increases the Hsp90 association to Akt. These data support the view that the antiapoptotic potential of CK2 is at least in part mediated by its ability to maintain Akt in its active form.
Akt(蛋白激酶B)是细胞存活通路中的一种关键激酶。其活性分别依赖于308位苏氨酸(Thr308)和473位丝氨酸(Ser473)被PDK1和mTORC2磷酸化。我们发现,Akt可被另一种激酶CK2通过对129位丝氨酸(Ser129)的磷酸化进一步激活。在此我们表明,Akt在Ser129位点的磷酸化还促进了它与热休克蛋白90(Hsp90)伴侣蛋白的结合,从而防止Thr308去磷酸化。以下观察结果支持了这一观点:(1)当Ser129突变为丙氨酸时,磷酸化的Thr308减少;(2)用冈田酸(使蛋白磷酸酶2A失活)或格尔德霉素(使Hsp90失活)处理细胞可消除这种减少;(3)Ser129的磷酸化既不增强PDK1的活性,也不妨碍蛋白磷酸酶2A对Thr308的体外活性,但会增加Hsp90与Akt的结合。这些数据支持了这样一种观点,即CK2的抗凋亡潜能至少部分是由其将Akt维持在活性形式的能力介导的。